Pan Yan, Sun Shuo, Wang Xingxing, Chen Aidong, Fei Xuejie, Wang Wei, Han Ying
Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center of Translational Medicine for Cardiovascular Disease, Nanjing Medical University, Nanjing, China.
Department of Physiology, Nanjing Medical University, Nanjing, China.
Front Physiol. 2021 Apr 9;12:622954. doi: 10.3389/fphys.2021.622954. eCollection 2021.
Salusin-β, a multifunctional vasoactive peptide, has a potentially important function in the pathological development of hypertension. However, the exact functional role of salusin-β and the underlying mechanism in this process are still not fully understood. The current study aimed to investigate the effects of silencing salusin-β on vascular function and vascular remodeling, as well as its signaling pathways in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY).
Silencing salusin-β was performed by caudal vein injection of adenovirus expressing salusin-β short hairpin RNA (shRNA). Acetylcholine (ACh)-induced endothelium-dependent relaxation was used to evaluate vasodilator function, and high K solution-induced constriction was used to evaluate vasoconstriction function.
Salusin-β levels in plasma and its protein expression in mesenteric artery (MA), coronary artery (CA), and pulmonary artery (PA) of SHR were higher than those in WKY. The salusin-β level and expression were decreased effectively by salusin-β shRNA. Knockdown of salusin-β decreased arterial blood pressure (ABP) and high K solution-induced vascular constrictions, and improved the endothelium-dependent relaxation and vascular remodeling in SHR. The improved effect of silencing salusin-β on ACh-induced relaxation in SHR was almost blocked by the nitric oxide synthase (NOS) inhibitor L-NAME. Compared to WKY, the endothelial NOS (eNOS) activity and level, and nitric oxide (NO) level were decreased, while NAD(P)H oxidase activity and reactive oxygen species (ROS) levels in MA, CA, and PA of SHR were increased, which were all redressed by salusin-β knockdown.
These results indicate that knockdown of salusin-β improves endothelium-dependent vascular relaxation and vascular remodeling and decreases ABP and vasoconstriction in SHR, which might be accomplished by increasing eNOS activation and NO release while inhibiting NAD(P)H oxidase derived-ROS generation. Scavenging salusin-β improves vascular function and then prevents the development and progression of vasculopathy of hypertension.
Salusin-β是一种多功能血管活性肽,在高血压的病理发展过程中具有潜在的重要作用。然而,Salusin-β的确切功能作用及其在此过程中的潜在机制仍未完全明确。本研究旨在探讨沉默Salusin-β对自发性高血压大鼠(SHR)和Wistar-Kyoto大鼠(WKY)血管功能、血管重塑及其信号通路的影响。
通过尾静脉注射表达Salusin-β短发夹RNA(shRNA)的腺病毒来沉默Salusin-β。采用乙酰胆碱(ACh)诱导的内皮依赖性舒张来评估血管舒张功能,用高钾溶液诱导的收缩来评估血管收缩功能。
SHR血浆中的Salusin-β水平及其在肠系膜动脉(MA)、冠状动脉(CA)和肺动脉(PA)中的蛋白表达均高于WKY。Salusin-β shRNA有效降低了Salusin-β水平和表达。沉默Salusin-β可降低SHR的动脉血压(ABP)和高钾溶液诱导的血管收缩,并改善其内皮依赖性舒张和血管重塑。一氧化氮合酶(NOS)抑制剂L-NAME几乎阻断了沉默Salusin-β对SHR中ACh诱导舒张的改善作用。与WKY相比,SHR的MA、CA和PA中内皮型NOS(eNOS)活性、水平及一氧化氮(NO)水平降低,而NAD(P)H氧化酶活性和活性氧(ROS)水平升高,沉默Salusin-β均可纠正这些变化。
这些结果表明,沉默Salusin-β可改善SHR的内皮依赖性血管舒张和血管重塑,降低ABP和血管收缩,这可能是通过增加eNOS激活和NO释放,同时抑制NAD(P)H氧化酶衍生的ROS生成来实现的。清除Salusin-β可改善血管功能,进而预防高血压血管病变的发生和发展。